U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882096) titled 'Tracing the Metabolic Flux of Orally Administered NAD+ Precursors' on March 11.
Brief Summary: We are doing this research to learn how healthy younger and older adults use two forms of vitamin B3-called nicotinamide mononucleotide (NMN) and nicotinamide (NAM)-to make NAD+. NAD+ is a natural substance that cells need for energy and other important processes. Our goal is to find out how these NAD precursors are absorbed and metabolized and how they raise NAD+ in different tissues.
Who can join? Healthy adults men and women aged 18 to 40 (younger group) or 65 and older (older group) Participants with a body mass index ranging between...